Clinical trial
Clinical Outcomes of Enamel Matrix Derivative and Connective Tissue Graft in Modified Coronally Advanced Tunnel: A Randomized Controlled Trial
NCT06504329 is registered in ClinicalTrials.gov with Necmettin Erbakan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Outcomes of Enamel Matrix Derivative and Connective Tissue Graft in Modified Coronally Advanced Tunnel: A Randomized Controlled Trial
- Lead sponsor
- Necmettin Erbakan University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 24, 2024
- Completion date
- January 24, 2025
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.